OKLAHOMA CITY, OK -- (Marketwired) -- 08/20/13 -- Cytovance Biologics, Inc., a leading full-service contract manufacturer of mammalian and microbial biologics, has recently been named as one of Oklahoma City's fastest growing private companies.
"We are delighted to be named one of the fastest growing companies in Oklahoma City and to receive this prestigious award," said Darren Head, Cytovance Biologics President and Chief Executive Officer. "Our employees are the foundation of this company and this recognition honors their hard work and commitment."
Cytovance Biologics currently employs 119 employees in the U.S. and is celebrating 10 years of service this year.
"Over the past ten years, our staff of experts has produced clinical products for clients worldwide for medical indications including cancer, diabetes, sickle-cell anemia and many others," Head explained. "We have remained committed to our mission of being a value-added partner to our clients by providing integral pathways of converting today's protein discoveries into future life-saving therapies. We are proud to be a thriving part of the biotech market in Oklahoma City."
Most recently the company announced expansions to its manufacturing capabilities that include larger bioreactors and an automated fill finish line. "We've come a long way since I started with the company in 2008," Head stated. "With the recent expansions, we are on track to employ a workforce of 145 and reach $22.5 million in sales by the end of 2013."
The Metro 50 Award allows both emerging companies, as well as companies that have exhibited substantial history as an established business, to be recognized. Metro 50 companies demonstrate positive growth in revenues; growth in the number of employees; creativity/entrepreneurship; and business development through the expansion of facilities, customer base or markets.
Companies will be honored at the 18th Annual Metro 50 ceremony on September 23 at the National Cowboy & Western Heritage Museum.
About Cytovance Biologics
Cytovance Biologics is a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. In addition to its cGMP manufacturing services, the company offers process development, cGMP cell banking and support services from its Oklahoma City state-of-the-art facilities.
Learn more about Cytovance Biologics at www.cytovance.com or visit with representatives at the BioProcess International Conference, September 16-20, 2013 in Boston, MA, booth #604.